Supporting Information PTD-Modified ATTEMPTS for Enhanced Toxin-based Cancer Therapy: An In Vivo Proof-of-Concept Study Meong Cheol Shina,b, Jian Zhangc, Kyoung Ah Minb, Huining Hea, Allan E. Davidd, Yongzhuo Huange and Victor C. Yanga,b,f* a Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnosis, School of Pharmacy, Tianjin Medical University, Tianjin 300070, China b Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, 428 Church St., Ann Arbor, MI 48109, USA c Biomedical Polymers Laboratory, and Jiangsu Key Laboratory of Advanced Functional Polymer Design and Application, Department of Polymer Science and Engineering, College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, China d Department of Chemical Engineering, Auburn University, Auburn, AL 36849, USA e Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Hai-ke Rd, Shanghai 201203, China f Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology, and College of Medicine or College of Pharmacy, Seoul National University, Seoul, 151-742, Republic of Korea * Author to whom correspondence should be addressed: Victor C. Yang, Ph.D. Albert B Prescott Professor Department of Pharmaceutical Sciences The University of Michigan Ann Arbor, Michigan 48109-1065 Tel: 01-734-764-4273; Fax: 01-734-763-9772 Email: vcyang@umich.edu Internalized TAT-Gel (%) 100 w/o Protamine with Protamine 80 60 40 ** ** ** ** 20 0 0 1 2 3 4 5 6 Incubation Time (h) Figure S1. Quantification of cell internalized TAT-Gel fractions with or without addition of protamine to the TAT-Gel/T84.66-Hep pre-treated cells. LS174T cells were seeded on 24-well plates at a density of 2×104 cells per well and, after overnight incubation, TAT-Gel (TRITClabeled)/T84.66-Hep (TAT-Gel: final 1 µM concentration; TAT : heparin = 1:3) were added to the wells and incubated at 37ºC for 2 h. After washing the unbound TAT-Gel/T84.66-Hep with PBS, the cells were further incubated at 37ºC up to 6 h with or without addition of protamine (final concentration: 3 µM). At intended time points (0, 0.5, 1, 2, 6h), the cell internalized TATGel amount was quantified by following the identical procedures used for quantification of the cell internalized T84.66-Hep (please see ‘MATERIALS AND METHODS’ section). The internalized TAT-Gel fraction (%) was calculated by dividing the mean fluorescence intensity (M.F.I.) of internalized TAT-Gel by the M.F.I. of total cell associated TAT-Gel (at time point “0”), and then multiplying by 100. The results showed that with addition of protamine, the cell internalization of TAT-Gel significantly increased (at 0.5 h, from 9.8% to 26% and, at 6h, 13.9% to 39.2%). **P < 0.01 by Student’s t-test. (TAT-Gel: recombinant TAT-gelonin fusion chimera, T84.66-Hep: T84.66-heparin chemical conjugate)